Meet Our Guests of Honor and Recipients of the 2019 Innovator Award

 

Nicholas Siciliano
Chief Executive Officer and Co-Founder

Invisible Sentinel - bioMérieux

Dr. Siciliano co-founded Invisible Sentinel in 2006 and was the lead inventor of the Company’s Veriflow technology. In his role as CEO, he sets corporate strategy, including sales and marketing initiatives and the identification of strategic partnerships. He also leads the R&D team, drawing on his more than 15 years of experience in microbiology, immunology, and assay development. He earned a B.S. in Chemistry from Villanova University and a Ph.D. in Immunology & Microbial Pathogenesis from Thomas Jefferson University. Formerly, Nick was a biomedical researcher in bacterial and viral pathogenesis, immunology, microbiology, and oncology, as well as a developer of antibody-based assays and consultant on projects in bacteriology, immunology, and antibody design. He has received several awards including Honoree on the annual “40 under 40” list compiled by the Philadelphia Business Journal to recognize outstanding entrepreneurs and business leaders. He was also a recipient of the 2015 Marcum/Smart CEO Innovator of the Year.

 

Ben Pascal
Chief Business Officer and Co-Founder

Invisible Sentinel - bioMérieux

Mr. Pascal co-founded Invisible Sentinel in 2006. In his role as Chief Business Officer, he focuses on marketing and business development. He also works closely with the Sales function of the Company, helping to define sales strategies, identifying potential clients, supporting system implementation at key corporate accounts, and opening new international markets for the Company. Formerly he was a product developer at B. Braun Medical and the National Institute for Medical Research (London). Ben is an inventor on a corresponding patent to an antibacterial device and team member in the design of a functional cellular vaccine against malaria. He received a BS degree from The George Washington University in Biology and Political Science and an MBA from Lehigh University.

​

About Invisible Sentinel

​

Invisible Sentinel, Inc., a global molecular solutions company based in Philadelphia, PA, is dedicated to providing first-in-class microbial detection tools. The company’s platform technologies, Veriflow® & Veripro™ are patent protected, molecular based technologies that integrate molecular diagnostics, antibody and probe design, and immunoassays. Veriflow® technology is currently applied across multiple industries including food safety and beverage quality. The company has commercialized or is developing solutions in other industries, such as healthcare, veterinary services, and environmental/water testing. Each solution requires specific design elements, but retains the inherent advantages of our technology: simplicity, accessibility, and affordability.  For more information, visit http://invisiblesentinel.com/.

​

About bioMérieux

Pioneering Diagnostics
 

A world leader in the field of in vitro diagnostics for over 55 years, bioMérieux is present in 43 countries and serves more than 160 countries with the support of a large network of distributors. In 2018, revenues reached €2.4 billion, with over 90% of international sales.

​

bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

For more information, visit https://www.biomerieux.com/en.

​

bioMérieux is listed on the NYSE Euronext Paris market (Symbol: BIM – ISIN: FR0013280286).

​

​

PRESS RELEASE:  France’s bioMerieux buys West Philly biotech firm for $75 million